Shopping Cart 0
Cart Subtotal
USD 0

Global Anti-Obesity Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2960

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3460

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 4500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 4500

Details

The Anti-Obesity Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Anti-Obesity Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Anti-Obesity Drugs market.

Major players in the global Anti-Obesity Drugs market include:

Takeda Pharmaceutical

Alizyme

Shionogi USA

FlaxoSithKline plc

GlaxoSmithKline

Norgine Pharmaceuticals Ltd.

Novo Nordisk

Orexigen Therapeutics

BoehringerIngelheim GmbH

Zafgen

Bristol-Myers Squibb

Pfizer

Rhythm Pharmaceuticals

F. Hoffmann La Roche

Eisai Co, Ltd.

Vivus

On the basis of types, the Anti-Obesity Drugs market is primarily split into:

Prescription Drugs

OTC Drugs

On the basis of applications, the market covers:

Men

Women

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Anti-Obesity Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Anti-Obesity Drugs market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Anti-Obesity Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Anti-Obesity Drugs market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Anti-Obesity Drugs, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Anti-Obesity Drugs in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Anti-Obesity Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Anti-Obesity Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Anti-Obesity Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Anti-Obesity Drugs market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

READ MORE

Table Of Content

Scope

Table of Contents

1 Anti-Obesity Drugs Market Overview

1.1 Product Overview and Scope of Anti-Obesity Drugs

1.2 Anti-Obesity Drugs Segment by Type

1.2.1 Global Anti-Obesity Drugs Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Prescription Drugs

1.2.3 The Market Profile of OTC Drugs

1.3 Global Anti-Obesity Drugs Segment by Application

1.3.1 Anti-Obesity Drugs Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Men

1.3.3 The Market Profile of Women

1.4 Global Anti-Obesity Drugs Market by Region (2014-2026)

1.4.1 Global Anti-Obesity Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3 Europe Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.1 Germany Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.2 UK Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.3 France Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.4 Italy Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.5 Spain Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.6 Russia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.7 Poland Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.4 China Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.5 Japan Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.6 India Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8 Central and South America Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Anti-Obesity Drugs (2014-2026)

1.5.1 Global Anti-Obesity Drugs Revenue Status and Outlook (2014-2026)

1.5.2 Global Anti-Obesity Drugs Production Status and Outlook (2014-2026)

2 Global Anti-Obesity Drugs Market Landscape by Player

2.1 Global Anti-Obesity Drugs Production and Share by Player (2014-2019)

2.2 Global Anti-Obesity Drugs Revenue and Market Share by Player (2014-2019)

2.3 Global Anti-Obesity Drugs Average Price by Player (2014-2019)

2.4 Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Anti-Obesity Drugs Market Competitive Situation and Trends

2.5.1 Anti-Obesity Drugs Market Concentration Rate

2.5.2 Anti-Obesity Drugs Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Takeda Pharmaceutical

3.1.1 Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.1.3 Takeda Pharmaceutical Anti-Obesity Drugs Market Performance (2014-2019)

3.1.4 Takeda Pharmaceutical Business Overview

3.2 Alizyme

3.2.1 Alizyme Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.2.3 Alizyme Anti-Obesity Drugs Market Performance (2014-2019)

3.2.4 Alizyme Business Overview

3.3 Shionogi USA

3.3.1 Shionogi USA Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.3.3 Shionogi USA Anti-Obesity Drugs Market Performance (2014-2019)

3.3.4 Shionogi USA Business Overview

3.4 FlaxoSithKline plc

3.4.1 FlaxoSithKline plc Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.4.3 FlaxoSithKline plc Anti-Obesity Drugs Market Performance (2014-2019)

3.4.4 FlaxoSithKline plc Business Overview

3.5 GlaxoSmithKline

3.5.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.5.3 GlaxoSmithKline Anti-Obesity Drugs Market Performance (2014-2019)

3.5.4 GlaxoSmithKline Business Overview

3.6 Norgine Pharmaceuticals Ltd.

3.6.1 Norgine Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.6.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Market Performance (2014-2019)

3.6.4 Norgine Pharmaceuticals Ltd. Business Overview

3.7 Novo Nordisk

3.7.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.7.3 Novo Nordisk Anti-Obesity Drugs Market Performance (2014-2019)

3.7.4 Novo Nordisk Business Overview

3.8 Orexigen Therapeutics

3.8.1 Orexigen Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.8.3 Orexigen Therapeutics Anti-Obesity Drugs Market Performance (2014-2019)

3.8.4 Orexigen Therapeutics Business Overview

3.9 BoehringerIngelheim GmbH

3.9.1 BoehringerIngelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.9.3 BoehringerIngelheim GmbH Anti-Obesity Drugs Market Performance (2014-2019)

3.9.4 BoehringerIngelheim GmbH Business Overview

3.10 Zafgen

3.10.1 Zafgen Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.10.3 Zafgen Anti-Obesity Drugs Market Performance (2014-2019)

3.10.4 Zafgen Business Overview

3.11 Bristol-Myers Squibb

3.11.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.11.3 Bristol-Myers Squibb Anti-Obesity Drugs Market Performance (2014-2019)

3.11.4 Bristol-Myers Squibb Business Overview

3.12 Pfizer

3.12.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.12.3 Pfizer Anti-Obesity Drugs Market Performance (2014-2019)

3.12.4 Pfizer Business Overview

3.13 Rhythm Pharmaceuticals

3.13.1 Rhythm Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.13.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Market Performance (2014-2019)

3.13.4 Rhythm Pharmaceuticals Business Overview

3.14 F. Hoffmann La Roche

3.14.1 F. Hoffmann La Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.14.3 F. Hoffmann La Roche Anti-Obesity Drugs Market Performance (2014-2019)

3.14.4 F. Hoffmann La Roche Business Overview

3.15 Eisai Co, Ltd.

3.15.1 Eisai Co, Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.15.3 Eisai Co, Ltd. Anti-Obesity Drugs Market Performance (2014-2019)

3.15.4 Eisai Co, Ltd. Business Overview

3.16 Vivus

3.16.1 Vivus Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.16.3 Vivus Anti-Obesity Drugs Market Performance (2014-2019)

3.16.4 Vivus Business Overview

4 Global Anti-Obesity Drugs Production, Revenue (Value), Price Trend by Type

4.1 Global Anti-Obesity Drugs Production and Market Share by Type (2014-2019)

4.2 Global Anti-Obesity Drugs Revenue and Market Share by Type (2014-2019)

4.3 Global Anti-Obesity Drugs Price by Type (2014-2019)

4.4 Global Anti-Obesity Drugs Production Growth Rate by Type (2014-2019)

4.4.1 Global Anti-Obesity Drugs Production Growth Rate of Prescription Drugs (2014-2019)

4.4.2 Global Anti-Obesity Drugs Production Growth Rate of OTC Drugs (2014-2019)

5 Global Anti-Obesity Drugs Market Analysis by Application

5.1 Global Anti-Obesity Drugs Consumption and Market Share by Application (2014-2019)

5.2 Global Anti-Obesity Drugs Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Anti-Obesity Drugs Consumption Growth Rate of Men (2014-2019)

5.2.2 Global Anti-Obesity Drugs Consumption Growth Rate of Women (2014-2019)

6 Global Anti-Obesity Drugs Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Anti-Obesity Drugs Consumption by Region (2014-2019)

6.2 United States Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.3 Europe Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.4 China Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.5 Japan Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.6 India Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

7 Global Anti-Obesity Drugs Production, Revenue (Value) by Region (2014-2019)

7.1 Global Anti-Obesity Drugs Production and Market Share by Region (2014-2019)

7.2 Global Anti-Obesity Drugs Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

8 Anti-Obesity Drugs Manufacturing Analysis

8.1 Anti-Obesity Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Anti-Obesity Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Anti-Obesity Drugs Industrial Chain Analysis

9.2 Raw Materials Sources of Anti-Obesity Drugs Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Anti-Obesity Drugs

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Anti-Obesity Drugs Market Forecast (2019-2026)

11.1 Global Anti-Obesity Drugs Production, Revenue Forecast (2019-2026)

11.1.1 Global Anti-Obesity Drugs Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Anti-Obesity Drugs Price and Trend Forecast (2019-2026)

11.2 Global Anti-Obesity Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Anti-Obesity Drugs Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Anti-Obesity Drugs Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source


List Of Figure

List of Tables and Figures

Figure Anti-Obesity Drugs Product Picture

Table Global Anti-Obesity Drugs Production and CAGR (%) Comparison by Type

Table Profile of Prescription Drugs

Table Profile of OTC Drugs

Table Anti-Obesity Drugs Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Men

Table Profile of Women

Figure Global Anti-Obesity Drugs Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Europe Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Germany Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure UK Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure France Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Italy Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Spain Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Russia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Poland Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure China Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Japan Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure India Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Malaysia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Singapore Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Philippines Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Indonesia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Thailand Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Vietnam Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Central and South America Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Brazil Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Mexico Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Colombia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Turkey Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Egypt Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure South Africa Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Nigeria Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Global Anti-Obesity Drugs Production Status and Outlook (2014-2026)

Table Global Anti-Obesity Drugs Production by Player (2014-2019)

Table Global Anti-Obesity Drugs Production Share by Player (2014-2019)

Figure Global Anti-Obesity Drugs Production Share by Player in 2018

Table Anti-Obesity Drugs Revenue by Player (2014-2019)

Table Anti-Obesity Drugs Revenue Market Share by Player (2014-2019)

Table Anti-Obesity Drugs Price by Player (2014-2019)

Table Anti-Obesity Drugs Manufacturing Base Distribution and Sales Area by Player

Table Anti-Obesity Drugs Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Takeda Pharmaceutical Profile

Table Takeda Pharmaceutical Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Alizyme Profile

Table Alizyme Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Shionogi USA Profile

Table Shionogi USA Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table FlaxoSithKline plc Profile

Table FlaxoSithKline plc Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Norgine Pharmaceuticals Ltd. Profile

Table Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Novo Nordisk Profile

Table Novo Nordisk Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Orexigen Therapeutics Profile

Table Orexigen Therapeutics Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table BoehringerIngelheim GmbH Profile

Table BoehringerIngelheim GmbH Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Zafgen Profile

Table Zafgen Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Bristol-Myers Squibb Profile

Table Bristol-Myers Squibb Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Rhythm Pharmaceuticals Profile

Table Rhythm Pharmaceuticals Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table F. Hoffmann La Roche Profile

Table F. Hoffmann La Roche Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Eisai Co, Ltd. Profile

Table Eisai Co, Ltd. Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Vivus Profile

Table Vivus Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Anti-Obesity Drugs Production by Type (2014-2019)

Table Global Anti-Obesity Drugs Production Market Share by Type (2014-2019)

Figure Global Anti-Obesity Drugs Production Market Share by Type in 2018

Table Global Anti-Obesity Drugs Revenue by Type (2014-2019)

Table Global Anti-Obesity Drugs Revenue Market Share by Type (2014-2019)

Figure Global Anti-Obesity Drugs Revenue Market Share by Type in 2018

Table Anti-Obesity Drugs Price by Type (2014-2019)

Figure Global Anti-Obesity Drugs Production Growth Rate of Prescription Drugs (2014-2019)

Figure Global Anti-Obesity Drugs Production Growth Rate of OTC Drugs (2014-2019)

Table Global Anti-Obesity Drugs Consumption by Application (2014-2019)

Table Global Anti-Obesity Drugs Consumption Market Share by Application (2014-2019)

Table Global Anti-Obesity Drugs Consumption of Men (2014-2019)

Table Global Anti-Obesity Drugs Consumption of Women (2014-2019)

Table Global Anti-Obesity Drugs Consumption by Region (2014-2019)

Table Global Anti-Obesity Drugs Consumption Market Share by Region (2014-2019)

Table United States Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Europe Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table China Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Japan Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table India Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Central and South America Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Global Anti-Obesity Drugs Production by Region (2014-2019)

Table Global Anti-Obesity Drugs Production Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Production Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Production Market Share by Region in 2018

Table Global Anti-Obesity Drugs Revenue by Region (2014-2019)

Table Global Anti-Obesity Drugs Revenue Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Revenue Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Revenue Market Share by Region in 2018

Table Global Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table China Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table India Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Anti-Obesity Drugs

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Anti-Obesity Drugs

Figure Anti-Obesity Drugs Industrial Chain Analysis

Table Raw Materials Sources of Anti-Obesity Drugs Major Players in 2018

Table Downstream Buyers

Figure Global Anti-Obesity Drugs Production and Growth Rate Forecast (2019-2026)

Figure Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2019-2026)

Figure Global Anti-Obesity Drugs Price and Trend Forecast (2019-2026)

Table United States Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table China Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table India Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Anti-Obesity Drugs Market Production Forecast, by Type

Table Global Anti-Obesity Drugs Production Volume Market Share Forecast, by Type

Table Global Anti-Obesity Drugs Market Revenue Forecast, by Type

Table Global Anti-Obesity Drugs Revenue Market Share Forecast, by Type

Table Global Anti-Obesity Drugs Price Forecast, by Type

Table Global Anti-Obesity Drugs Market Production Forecast, by Application

Table Global Anti-Obesity Drugs Production Volume Market Share Forecast, by Application

Table Global Anti-Obesity Drugs Market Revenue Forecast, by Application

Table Global Anti-Obesity Drugs Revenue Market Share Forecast, by Application

Table Global Anti-Obesity Drugs Price Forecast, by Application

Licence Rights

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

The Anti-Obesity Drugs market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Anti-Obesity Drugs market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Anti-Obesity Drugs market.

Major players in the global Anti-Obesity Drugs market include:

Takeda Pharmaceutical

Alizyme

Shionogi USA

FlaxoSithKline plc

GlaxoSmithKline

Norgine Pharmaceuticals Ltd.

Novo Nordisk

Orexigen Therapeutics

BoehringerIngelheim GmbH

Zafgen

Bristol-Myers Squibb

Pfizer

Rhythm Pharmaceuticals

F. Hoffmann La Roche

Eisai Co, Ltd.

Vivus

On the basis of types, the Anti-Obesity Drugs market is primarily split into:

Prescription Drugs

OTC Drugs

On the basis of applications, the market covers:

Men

Women

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Anti-Obesity Drugs market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Anti-Obesity Drugs market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Anti-Obesity Drugs industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Anti-Obesity Drugs market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Anti-Obesity Drugs, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Anti-Obesity Drugs in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Anti-Obesity Drugs in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Anti-Obesity Drugs. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Anti-Obesity Drugs market, including the global production and revenue forecast, regional forecast. It also foresees the Anti-Obesity Drugs market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

READ MORE

Scope

Table of Contents

1 Anti-Obesity Drugs Market Overview

1.1 Product Overview and Scope of Anti-Obesity Drugs

1.2 Anti-Obesity Drugs Segment by Type

1.2.1 Global Anti-Obesity Drugs Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Prescription Drugs

1.2.3 The Market Profile of OTC Drugs

1.3 Global Anti-Obesity Drugs Segment by Application

1.3.1 Anti-Obesity Drugs Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Men

1.3.3 The Market Profile of Women

1.4 Global Anti-Obesity Drugs Market by Region (2014-2026)

1.4.1 Global Anti-Obesity Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3 Europe Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.1 Germany Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.2 UK Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.3 France Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.4 Italy Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.5 Spain Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.6 Russia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.3.7 Poland Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.4 China Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.5 Japan Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.6 India Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8 Central and South America Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Anti-Obesity Drugs Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Anti-Obesity Drugs (2014-2026)

1.5.1 Global Anti-Obesity Drugs Revenue Status and Outlook (2014-2026)

1.5.2 Global Anti-Obesity Drugs Production Status and Outlook (2014-2026)

2 Global Anti-Obesity Drugs Market Landscape by Player

2.1 Global Anti-Obesity Drugs Production and Share by Player (2014-2019)

2.2 Global Anti-Obesity Drugs Revenue and Market Share by Player (2014-2019)

2.3 Global Anti-Obesity Drugs Average Price by Player (2014-2019)

2.4 Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Anti-Obesity Drugs Market Competitive Situation and Trends

2.5.1 Anti-Obesity Drugs Market Concentration Rate

2.5.2 Anti-Obesity Drugs Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Takeda Pharmaceutical

3.1.1 Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.1.3 Takeda Pharmaceutical Anti-Obesity Drugs Market Performance (2014-2019)

3.1.4 Takeda Pharmaceutical Business Overview

3.2 Alizyme

3.2.1 Alizyme Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.2.3 Alizyme Anti-Obesity Drugs Market Performance (2014-2019)

3.2.4 Alizyme Business Overview

3.3 Shionogi USA

3.3.1 Shionogi USA Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.3.3 Shionogi USA Anti-Obesity Drugs Market Performance (2014-2019)

3.3.4 Shionogi USA Business Overview

3.4 FlaxoSithKline plc

3.4.1 FlaxoSithKline plc Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.4.3 FlaxoSithKline plc Anti-Obesity Drugs Market Performance (2014-2019)

3.4.4 FlaxoSithKline plc Business Overview

3.5 GlaxoSmithKline

3.5.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.5.3 GlaxoSmithKline Anti-Obesity Drugs Market Performance (2014-2019)

3.5.4 GlaxoSmithKline Business Overview

3.6 Norgine Pharmaceuticals Ltd.

3.6.1 Norgine Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.6.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Market Performance (2014-2019)

3.6.4 Norgine Pharmaceuticals Ltd. Business Overview

3.7 Novo Nordisk

3.7.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.7.3 Novo Nordisk Anti-Obesity Drugs Market Performance (2014-2019)

3.7.4 Novo Nordisk Business Overview

3.8 Orexigen Therapeutics

3.8.1 Orexigen Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.8.3 Orexigen Therapeutics Anti-Obesity Drugs Market Performance (2014-2019)

3.8.4 Orexigen Therapeutics Business Overview

3.9 BoehringerIngelheim GmbH

3.9.1 BoehringerIngelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.9.3 BoehringerIngelheim GmbH Anti-Obesity Drugs Market Performance (2014-2019)

3.9.4 BoehringerIngelheim GmbH Business Overview

3.10 Zafgen

3.10.1 Zafgen Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.10.3 Zafgen Anti-Obesity Drugs Market Performance (2014-2019)

3.10.4 Zafgen Business Overview

3.11 Bristol-Myers Squibb

3.11.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.11.3 Bristol-Myers Squibb Anti-Obesity Drugs Market Performance (2014-2019)

3.11.4 Bristol-Myers Squibb Business Overview

3.12 Pfizer

3.12.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.12.3 Pfizer Anti-Obesity Drugs Market Performance (2014-2019)

3.12.4 Pfizer Business Overview

3.13 Rhythm Pharmaceuticals

3.13.1 Rhythm Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.13.3 Rhythm Pharmaceuticals Anti-Obesity Drugs Market Performance (2014-2019)

3.13.4 Rhythm Pharmaceuticals Business Overview

3.14 F. Hoffmann La Roche

3.14.1 F. Hoffmann La Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.14.3 F. Hoffmann La Roche Anti-Obesity Drugs Market Performance (2014-2019)

3.14.4 F. Hoffmann La Roche Business Overview

3.15 Eisai Co, Ltd.

3.15.1 Eisai Co, Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.15.3 Eisai Co, Ltd. Anti-Obesity Drugs Market Performance (2014-2019)

3.15.4 Eisai Co, Ltd. Business Overview

3.16 Vivus

3.16.1 Vivus Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Anti-Obesity Drugs Product Profiles, Application and Specification

3.16.3 Vivus Anti-Obesity Drugs Market Performance (2014-2019)

3.16.4 Vivus Business Overview

4 Global Anti-Obesity Drugs Production, Revenue (Value), Price Trend by Type

4.1 Global Anti-Obesity Drugs Production and Market Share by Type (2014-2019)

4.2 Global Anti-Obesity Drugs Revenue and Market Share by Type (2014-2019)

4.3 Global Anti-Obesity Drugs Price by Type (2014-2019)

4.4 Global Anti-Obesity Drugs Production Growth Rate by Type (2014-2019)

4.4.1 Global Anti-Obesity Drugs Production Growth Rate of Prescription Drugs (2014-2019)

4.4.2 Global Anti-Obesity Drugs Production Growth Rate of OTC Drugs (2014-2019)

5 Global Anti-Obesity Drugs Market Analysis by Application

5.1 Global Anti-Obesity Drugs Consumption and Market Share by Application (2014-2019)

5.2 Global Anti-Obesity Drugs Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Anti-Obesity Drugs Consumption Growth Rate of Men (2014-2019)

5.2.2 Global Anti-Obesity Drugs Consumption Growth Rate of Women (2014-2019)

6 Global Anti-Obesity Drugs Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Anti-Obesity Drugs Consumption by Region (2014-2019)

6.2 United States Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.3 Europe Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.4 China Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.5 Japan Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.6 India Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

7 Global Anti-Obesity Drugs Production, Revenue (Value) by Region (2014-2019)

7.1 Global Anti-Obesity Drugs Production and Market Share by Region (2014-2019)

7.2 Global Anti-Obesity Drugs Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

8 Anti-Obesity Drugs Manufacturing Analysis

8.1 Anti-Obesity Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Anti-Obesity Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Anti-Obesity Drugs Industrial Chain Analysis

9.2 Raw Materials Sources of Anti-Obesity Drugs Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Anti-Obesity Drugs

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Anti-Obesity Drugs Market Forecast (2019-2026)

11.1 Global Anti-Obesity Drugs Production, Revenue Forecast (2019-2026)

11.1.1 Global Anti-Obesity Drugs Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Anti-Obesity Drugs Price and Trend Forecast (2019-2026)

11.2 Global Anti-Obesity Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Anti-Obesity Drugs Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Anti-Obesity Drugs Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source


List Of Figure

List of Tables and Figures

Figure Anti-Obesity Drugs Product Picture

Table Global Anti-Obesity Drugs Production and CAGR (%) Comparison by Type

Table Profile of Prescription Drugs

Table Profile of OTC Drugs

Table Anti-Obesity Drugs Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Men

Table Profile of Women

Figure Global Anti-Obesity Drugs Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Europe Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Germany Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure UK Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure France Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Italy Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Spain Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Russia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Poland Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure China Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Japan Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure India Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Malaysia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Singapore Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Philippines Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Indonesia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Thailand Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Vietnam Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Central and South America Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Brazil Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Mexico Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Colombia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Turkey Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Egypt Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure South Africa Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Nigeria Anti-Obesity Drugs Revenue and Growth Rate (2014-2026)

Figure Global Anti-Obesity Drugs Production Status and Outlook (2014-2026)

Table Global Anti-Obesity Drugs Production by Player (2014-2019)

Table Global Anti-Obesity Drugs Production Share by Player (2014-2019)

Figure Global Anti-Obesity Drugs Production Share by Player in 2018

Table Anti-Obesity Drugs Revenue by Player (2014-2019)

Table Anti-Obesity Drugs Revenue Market Share by Player (2014-2019)

Table Anti-Obesity Drugs Price by Player (2014-2019)

Table Anti-Obesity Drugs Manufacturing Base Distribution and Sales Area by Player

Table Anti-Obesity Drugs Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Takeda Pharmaceutical Profile

Table Takeda Pharmaceutical Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Alizyme Profile

Table Alizyme Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Shionogi USA Profile

Table Shionogi USA Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table FlaxoSithKline plc Profile

Table FlaxoSithKline plc Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Norgine Pharmaceuticals Ltd. Profile

Table Norgine Pharmaceuticals Ltd. Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Novo Nordisk Profile

Table Novo Nordisk Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Orexigen Therapeutics Profile

Table Orexigen Therapeutics Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table BoehringerIngelheim GmbH Profile

Table BoehringerIngelheim GmbH Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Zafgen Profile

Table Zafgen Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Bristol-Myers Squibb Profile

Table Bristol-Myers Squibb Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Rhythm Pharmaceuticals Profile

Table Rhythm Pharmaceuticals Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table F. Hoffmann La Roche Profile

Table F. Hoffmann La Roche Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Eisai Co, Ltd. Profile

Table Eisai Co, Ltd. Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Vivus Profile

Table Vivus Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Anti-Obesity Drugs Production by Type (2014-2019)

Table Global Anti-Obesity Drugs Production Market Share by Type (2014-2019)

Figure Global Anti-Obesity Drugs Production Market Share by Type in 2018

Table Global Anti-Obesity Drugs Revenue by Type (2014-2019)

Table Global Anti-Obesity Drugs Revenue Market Share by Type (2014-2019)

Figure Global Anti-Obesity Drugs Revenue Market Share by Type in 2018

Table Anti-Obesity Drugs Price by Type (2014-2019)

Figure Global Anti-Obesity Drugs Production Growth Rate of Prescription Drugs (2014-2019)

Figure Global Anti-Obesity Drugs Production Growth Rate of OTC Drugs (2014-2019)

Table Global Anti-Obesity Drugs Consumption by Application (2014-2019)

Table Global Anti-Obesity Drugs Consumption Market Share by Application (2014-2019)

Table Global Anti-Obesity Drugs Consumption of Men (2014-2019)

Table Global Anti-Obesity Drugs Consumption of Women (2014-2019)

Table Global Anti-Obesity Drugs Consumption by Region (2014-2019)

Table Global Anti-Obesity Drugs Consumption Market Share by Region (2014-2019)

Table United States Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Europe Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table China Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Japan Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table India Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Central and South America Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export, Import (2014-2019)

Table Global Anti-Obesity Drugs Production by Region (2014-2019)

Table Global Anti-Obesity Drugs Production Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Production Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Production Market Share by Region in 2018

Table Global Anti-Obesity Drugs Revenue by Region (2014-2019)

Table Global Anti-Obesity Drugs Revenue Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Revenue Market Share by Region (2014-2019)

Figure Global Anti-Obesity Drugs Revenue Market Share by Region in 2018

Table Global Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table China Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table India Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Anti-Obesity Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Anti-Obesity Drugs

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Anti-Obesity Drugs

Figure Anti-Obesity Drugs Industrial Chain Analysis

Table Raw Materials Sources of Anti-Obesity Drugs Major Players in 2018

Table Downstream Buyers

Figure Global Anti-Obesity Drugs Production and Growth Rate Forecast (2019-2026)

Figure Global Anti-Obesity Drugs Revenue and Growth Rate Forecast (2019-2026)

Figure Global Anti-Obesity Drugs Price and Trend Forecast (2019-2026)

Table United States Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table China Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table India Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Anti-Obesity Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Anti-Obesity Drugs Market Production Forecast, by Type

Table Global Anti-Obesity Drugs Production Volume Market Share Forecast, by Type

Table Global Anti-Obesity Drugs Market Revenue Forecast, by Type

Table Global Anti-Obesity Drugs Revenue Market Share Forecast, by Type

Table Global Anti-Obesity Drugs Price Forecast, by Type

Table Global Anti-Obesity Drugs Market Production Forecast, by Application

Table Global Anti-Obesity Drugs Production Volume Market Share Forecast, by Application

Table Global Anti-Obesity Drugs Market Revenue Forecast, by Application

Table Global Anti-Obesity Drugs Revenue Market Share Forecast, by Application

Table Global Anti-Obesity Drugs Price Forecast, by Application

Single User License:

1. The Single User License allows for the use of a report by a single user within one corporate location.

2. The report paper copy may not be reproduced .

3. Report PDF copy cannot be copied (if purchased) and must remain on one computer.

4. Only a single copy of the publication may be printed for internal use.

5.  Users may include information in the report in presentations and internal reports by providing full copyright credit to Maia Research.

6.   Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

 

Enterprise License:

1. The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.

2. Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.

3. Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Maia Research.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS